- CONSORT Statement
- CONSORT Statement Extensions
- Evidence underpinning CONSORT
- Accrual and sample size
- Attitudes to trials
- Adverse events (Harms)
- Baseline data
- Blinding
- Compliance
- Early stopping
- Eligibility
- Follow-up
- Funding
- Harms
- Generalizability
- Intention to treat
- Interpretation
- Interventions
- Outcome reporting
- Random allocation
- Recruitment
- Statistical analysis
- Statistical methods
- Trial design issues
- Trial registration
- Uptake of CONSORT by journals
- Impact of and adherence to CONSORT
- Endorsement of CONSORT
Accrual and Sample size
Adetugbo K, Williams H. How well are randomized controlled
trials reported in the dermatology literature? Arch Dermatol 2000;
136(3):381-385.
PMID: 10724201
Altman DG, Bland JM. Absence of evidence is not evidence of absence.
BMJ 1995; 311(7003):485.
PMID: 7647644
Bromhead HJ, Goodman NW. CONSORT statement on the reporting
standards of clinical trials. Reporting of refusal of consent to take part in
clinical trials is still poor. BMJ 1997; 314(7087):1126-1127.
PMID: 9133903
Campbell MJ, Julious SA, Altman DG. Estimating sample sizes
for binary, ordered categorical, and continuous outcomes in two group
comparisons. BMJ 1995; 311(7013):1145-1148.
PMID: 7580713
Caubet JF, Stason WB, Bishop DJ, Ross SD. Sample sizes and
withdrawals in clinical trials. Lancet 1996; 348(9031):895.
PMID: 8826835
Chan AW, Altman DG. Epidemiology and reporting of
randomised trials published in PubMed journals. Lancet 2005;
365(9465):1159-1162.
PMID: 15794971
Charles P, Giraudeau B, Dechartres A, Baron G, Ravaud P. Reporting of sample size calculation in randomised controlled trials: review. BMJ 2009; 338:b1732.
PMID: 19435763 [New]
Freiman JA, Chalmers TC, Smith H, Jr.,
Kuebler RR. The importance of beta, the type II error and sample size in the
design and interpretation of the randomized control trial. Survey of 71
"negative" trials. N Engl J Med 1978; 299(13):690-694.
PMID: 355881
Kjaergard LL, Villumsen J, Gluud C. Reported methodologic
quality and discrepancies between large and small randomized trials in meta-analyses.
Ann Intern Med 2001; 135(11):982-989.
PMID: 11730399
Moher D, Dulberg CS, Wells GA. Statistical power, sample
size, and their reporting in randomized controlled trials. JAMA 1994;
272(2):122-124.
PMID: 8015121
Mulward S, GΓΈtzsche PC. Sample size of randomized
double-blind trials 1976-1991. Dan Med Bull 1996; 43(1):96-98.
PMID: 8906985
Ray JG, Vermeulen MJ. Sample size estimation for the
sorcerer's apprentice. Guide for the uninitiated and intimidated. Can Fam
Physician 1999; 45:1732-1739.
PMID: 10424273
van der Lee JH, Wesseling J, Tanck MW, Offringa M. Sequential design with boundaries approach in pediatric intervention research reduces sample size. J Clin Epidemiol 2010; 63(1):19-27.
PMID: 19788954 [New]
Vickers AJ. Underpowering in randomized trials reporting a
sample size calculation. J Clin Epidemiol 2003; 56(8):717-720.
PMID: 12954462
Yusuf S, Collins R, Peto R. Why do we need some large,
simple randomized trials? Stat Med 1984; 3(4):409-422.
PMID: 6528136
Page last edited: 23 March 2010
